06.09.23 -- Strategies To Streamline Combination Product Development For Biosimilars

The biosimilar development market is becoming increasingly competitive, putting first-to-market companies at a key advantage. A partner that can help sponsors manage costs will be essential to achieve commercial success. Discover how to de-risk the launch process by choosing a suitable autoinjector technology and partner.

An experienced partner with deep domain knowledge is key for developing robust, well-designed systems. Learn more as experts discuss the benefits of using integrated systems for sophisticated drug device combination products with multiple device subsystems, and the crucial role a partner can play as systems integrator.

Developing an effective drug-device combination product for self-administered biologics is a complex process. It requires critical decisions during delivery system selection, and making the right choices at an early stage can reduce risks. Ultimately, a well-executed strategy will help support integration with manufacturing operations and successful drug delivery.